J. Don Chen
J. Don Chen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Hui Li
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605; and †Nuclear Receptors Discovery Research, GlaxoSmithKline Research and Development, Research Triangle Park, NC 27709
3 shared publicationsEun-Ju Park
From the Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01655
2 shared publicationsXiaoyang Wu
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA
2 shared publicationsAihua Zhang
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605; and †Nuclear Receptors Discovery Research, GlaxoSmithKline Research and Development, Research Triangle Park, NC 27709
1 shared publicationChristopher Leo
Departments of Pharmacology and Molecular Toxicology and Cell Biology, Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts 01655
1 shared publicationH. Eric Xu
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605; and †Nuclear Receptors Discovery Research, GlaxoSmithKline Research and Development, Research Triangle Park, NC 27709
1 shared publication
Latest Publications
- Open Access
- 23 April 2002
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (9) , 5842-5847
Interactions that determine the assembly of a retinoid X receptor/corepressor complex
The retinoid X receptor (RXR) is a key regulator in multiple signaling pathways because it can form either a homodimer with itself or a heterodimer with members of the class I nuclear receptors. The RXR-containing dimers regulate transcription by recruiting coactivators or corepressors to the target promoters. The binding of coactivators to RXR is mediated through a hydrophobic pocket formed in part by the C-terminal activation helix (AF-2). However, little is known about interactions of corepressors with RXR and its roles in transcriptional repression. Here we show that the repression activity of RXR correlates with its binding to the corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT). This intrinsic repression activity is masked by the AF-2 helix, which antagonizes SMRT binding. Inhibition of SMRT binding by the AF-2 helix requires specific amino acid sequences and the helical structure. Furthermore, the SMRT-binding site on RXR is independent of helix 11 but overlaps with the coactivator-binding pocket. On the basis of these results, we propose a structural model to help understand the molecular mechanism of corepressor recruitment by RXR.
- 23 April 2002
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (9) , 5842-5847
Open AccessInteractions that determine the assembly of a retinoid X receptor/corepressor complex
The retinoid X receptor (RXR) is a key regulator in multiple signaling pathways because it can form either a homodimer with itself or a heterodimer with members of the class I nuclear receptors. The RXR-containing dimers regulate transcription by recruiting coactivators or corepressors to the target promoters. The binding of coactivators to RXR is mediated through a hydrophobic pocket formed in part by the C-terminal activation helix (AF-2). However, little is known about interactions of corepressors with RXR and its roles in transcriptional repression. Here we show that the repression activity of RXR correlates with its binding to the corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT). This intrinsic repression activity is masked by the AF-2 helix, which antagonizes SMRT binding. Inhibition of SMRT binding by the AF-2 helix requires specific amino acid sequences and the helical structure. Furthermore, the SMRT-binding site on RXR is independent of helix 11 but overlaps with the coactivator-binding pocket. On the basis of these results, we propose a structural model to help understand the molecular mechanism of corepressor recruitment by RXR.
- Open Access
- 1 June 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (26) , 24177-24185
SMRTe Inhibits MEF2C Transcriptional Activation by Targeting HDAC4 and 5 to Nuclear Domains
- 1 June 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (26) , 24177-24185
Open AccessSMRTe Inhibits MEF2C Transcriptional Activation by Targeting HDAC4 and 5 to Nuclear Domains
- 1 September 2000
- Published by Elsevier in Current Opinion in Cell Biology
- Vol. 12 (5) , 641-644
PML and the oncogenic nuclear domains in regulating transcriptional repression
- 1 September 2000
- Published by Elsevier in Current Opinion in Cell Biology
- Vol. 12 (5) , 641-644
PML and the oncogenic nuclear domains in regulating transcriptional repression
- 1 March 2000
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 20 (5) , 1784-1796
Sequestration and Inhibition of Daxx-Mediated Transcriptional Repression by PML
PML fuses with retinoic acid receptor α (RARα) in the t(15;17) translocation that causes acute promyelocytic leukemia (APL). In addition to localizing diffusely throughout the nucleoplasm, PML mainly resides in discrete nuclear structures known as PML oncogenic domains (PODs), which are disrupted in APL and spinocellular ataxia cells. We isolated the Fas-binding protein Daxx as a PML-interacting protein in a yeast two-hybrid screen. Biochemical and immunofluorescence analyses reveal that Daxx is a nuclear protein that interacts and colocalizes with PML in the PODs. Reporter gene assay shows that Daxx drastically represses basal transcription, likely by recruiting histone deacetylases. PML, but not its oncogenic fusion PML-RARα, inhibits the repressor function of Daxx. In addition, SUMO-1 modification of PML is required for sequestration of Daxx to the PODs and for efficient inhibition of Daxx-mediated transcriptional repression. Consistently, Daxx is found at condensed chromatin in cells that lack PML. These data suggest that Daxx is a novel nuclear protein bearing transcriptional repressor activity that may be regulated by interaction with PML.
- 1 March 2000
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 20 (5) , 1784-1796
Sequestration and Inhibition of Daxx-Mediated Transcriptional Repression by PML
PML fuses with retinoic acid receptor α (RARα) in the t(15;17) translocation that causes acute promyelocytic leukemia (APL). In addition to localizing diffusely throughout the nucleoplasm, PML mainly resides in discrete nuclear structures known as PML oncogenic domains (PODs), which are disrupted in APL and spinocellular ataxia cells. We isolated the Fas-binding protein Daxx as a PML-interacting protein in a yeast two-hybrid screen. Biochemical and immunofluorescence analyses reveal that Daxx is a nuclear protein that interacts and colocalizes with PML in the PODs. Reporter gene assay shows that Daxx drastically represses basal transcription, likely by recruiting histone deacetylases. PML, but not its oncogenic fusion PML-RARα, inhibits the repressor function of Daxx. In addition, SUMO-1 modification of PML is required for sequestration of Daxx to the PODs and for efficient inhibition of Daxx-mediated transcriptional repression. Consistently, Daxx is found at condensed chromatin in cells that lack PML. These data suggest that Daxx is a novel nuclear protein bearing transcriptional repressor activity that may be regulated by interaction with PML.